BioMarker Strategies Names Greg Bertenshaw Chief Operating and Science Officer
Dr. Bertenshaw, formerly Vice President, Research & Development, will continue to report directly to Jerry Parrott, President and Chief Executive Officer.
NYU Winthrop Physician Paula Lester MD, FACP, CMD Authors COVID-19 Safety Recommendations
"The scope and speed of the COVID-19 pandemic brought continual changes in healthcare protocols as providers learned more about the disease's transmission," said Paula Lester, MD, FACP, CMD, a geriatrician at NYU Winthrop Hospital and the corresponding author of the consensus recommendations, which were recently published online in Journal of American Medical Directors Association.
The Annals of Thoracic Surgery Published In Vivo Study Concludes Hemovent’s MOBYBOX ECLS Device Provides “Excellent (Long-Term) Safety and Physiologic Efficacy”
Hemovent reports the study concluded that Hemovent’s MOBYBOX ECLS device “provides excellent safety and physiologic efficacy in a 7-day (long-term) sheep experiment without visible clotting, hemolysis, or sustained reductions in fibrinogen or platelets.”
Dr. Jean-Claude Dubacher Appointed Chairman and Chief Executive Officer of B. Braun of America Inc.
Dr. Dubacher joined B. Braun in August 2019 as President, B. Braun Medical Inc., and became Chairman and Chief Executive Officer of B. Braun Medical Inc. on January 1, 2020.
Board Member Caroll H. Neubauer Retires from B. Braun
Carroll H. Neubauer led B. Braun's operations in North America since 1996, overseeing the organization's steady growth from $247 million in annual revenue to more than $2 billion with over 8,000 employees in 2019.